Search PubMedSearch

Biomedical subjects

Zhao-Qi Wang

Publications and source records attributed to Zhao-Qi Wang.

2 recordsLinked to original sources

Differential DNA damage vulnerability in human neuropathies.

The maintenance of genomic integrity is a fundamental prerequisite for tissue homeostasis, which is critical for central nervous system (CNS) function. During neurogenesis, the transition from rapidly proliferating neuroprogenitors to post-mitotic neurons entails a fundamental shift in genotoxic threats, which must be addressed by the robust DNA damage response (DDR) network. The spatiotemporal utilisation of distinct DDR pathways in different neural cell types establishes heterogeneous vulnerabilities in specific brain regions to pathological processes. While the cerebrum exhibits varying or negligible degrees of sensitivity to DDR defects, cerebellar atrophy and degeneration are common hallmarks of various human genomic instability syndromes (GIS). Biomedical and cellular studies of human GIS and the corresponding mouse models have shed light on the aetiology of the associated neuropathies; however, cerebellar vulnerability to DDR defects remains poorly understood. Here, we review the cell type- and species-specific divergences in DDR reliance in different brain regions, along with the corresponding DDR pathways underpinning the distinct susceptibility of neuropathological manifestations.

Animal model

PARP1 UFMylation ensures the stability of stalled replication forks.

The S-phase checkpoint involving CHK1 is essential for fork stability in response to fork stalling. PARP1 acts as a sensor of replication stress and is required for CHK1 activation. However, it is unclear how the activity of PARP1 is regulated. Here, we found that UFMylation is required for the efficient activation of CHK1 by UFMylating PARP1 at K548 during replication stress. Inactivation of UFL1, the E3 enzyme essential for UFMylation, delayed CHK1 activation and inhibits nascent DNA degradation during replication blockage as seen in PARP1-deficient cells. An in vitro study indicated that PARP1 is UFMylated at K548, which enhances its catalytic activity. Correspondingly, a PARP1 UFMylation-deficient mutant (K548R) and pathogenic mutant (F553L) compromised CHK1 activation, the restart of stalled replication forks following replication blockage, and chromosome stability. Defective PARP1 UFMylation also resulted in excessive nascent DNA degradation at stalled replication forks. Finally, we observed that PARP1 UFMylation-deficient knock-in mice exhibited increased sensitivity to replication stress caused by anticancer treatments. Thus, we demonstrate that PARP1 UFMylation promotes CHK1 activation and replication fork stability during replication stress, thus safeguarding genome integrity.

DNA Replication